Directorate Change

RNS Number : 4716V
Reckitt Benckiser Group PLC
28 October 2014
 



 

 

28 October 2014

 

DIRECTORATE CHANGE

 

 

 

Reckitt Benckiser Group plc (RB) today announces the appointment of Doug Tough as an independent non-executive director, effective 1 November 2014.

 

 

Mr Tough, Canadian/American, is, until 1 December 2014, the Chairman of International Flavors & Fragrances Inc. (IFF), a leading global creator of flavours and fragrances used in a wide array of consumer products. He joined IFF as an independent non-executive director in 2008 and served as both CEO and Chairman from March 2010 until September 2014. Between 2004 and 2010 Mr Tough was CEO and Managing Director of Ansell Limited, a global leader in healthcare barrier protection.  Prior to Ansell, Mr. Tough served in a variety of executive positions over a 17-year period with Cadbury Schweppes Plc, a major food and beverage company. He adds further international diversity to the RB board.  

 

Adrian Bellamy, Chairman of RB, commented:

 

"We are delighted that Doug has agreed to join us. He brings a wealth of international consumer business experience to the Board and we expect his time at Ansell, within the healthcare sector, to be of particular value in our future deliberations.

 

We look forward to welcoming Doug to the Board. "

 

 

Mr Tough is also a director of Molson Coors Brewing Company, a US publicly traded corporation.  There are no further details required to be disclosed under Listing Rule 9.6.13.

 

 

 

 

 For Further Information
Andraea Dawson-Shepherd

SVP Global Corporate Communication and Affairs
Telephone                     +44 (0) 1753 217 800

William R. Mordan      

Company Secretary
Telephone                     +44 (0) 1753 217 800

 

 

 

 

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in the UK, Singapore, Dubai and Amsterdam, and sales in almost 200 countries. The company employs approximately 37,000 people worldwide.

With a purpose of delivering innovative solutions for healthier lives and happier homes, RB is in the top 20 of companies listed on the London Stock Exchange. Today it is the global No 1or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands of  Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Clearasil, Woolite, Dettol, Veet, Harpic, Bang,  Mortein, Finish, Vanish, Calgon, Air Wick, and French's.  At the start of 2014 RB had 43% of its core revenues coming from its 2 emerging market Areas and 57% from its developed market Area; 72% of core revenues came from the health and hygiene categories of the portfolio.

 

Fuelled by a new breed of talent who blend intellectual curiosity with commitment to the highest quality standards, RB is set to redefine the world of consumer health and hygiene.  RB people and its culture are at the heart of the company's success. They have an intense drive for achievement and a desire to outperform wherever they focus, including in sustainability where the company is targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and to have 1/3 of its net revenue coming from more sustainable products by 2020. It is also the Save the Children charity's largest FMCG global partner, with a new partnership vision to radically reduce the world's second biggest killer of under-fives, diarrhoea.  Overall RB wants to reach 200 million people to improve their health and hygiene behaviour.  

 


For more information visit
www.rb.com 

 

*RB is the trading name of Reckitt Benckiser group of companies

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGMCUUPCGGR
UK 100

Latest directors dealings